Investor Presentaiton
INTERNATIONAL MEDICAL: DEMAND FOR QUALITY CANADIAN
CANNABIS IS EXPECTED TO DRIVE GROWTH OPPORTUNITIES
•
.
•
Recognition of Canadian cannabis product quality is spurring
demand from International medical markets
Leveraging strong demand, the Company started shipping 5 new
SKUs to international medical markets in Q3 FY2024; Additional
product SKUs are expected to be launched over the coming
months
Focus on growing Australian medical cannabis market; Australia
generated 10th straight quarter of revenue growth in Q2 FY2024
Refining our business processes to capitalize on growth
opportunities that we see in other markets including Germany,
Poland and the Czech Republic
EU-GMP certification of the Kincardine, Ontario cultivation facility
strengthens ability to supply International medical markets
11View entire presentation